ArticleCellular oncology (Dordrecht, Netherlands)2019

Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.

Lihua Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.